London lands ahead of the University of Oxford and the University of Cambridge (Table 1) . Gene-editing pioneer Horizon Discovery (Cambridge, UK) notably closed five academic deals last year, which was more than several big pharma companies (Fig. 2) . Brady Huggett is Business Editor, Nature Biotechnology.
An analysis of 387 public-private partnerships (including research institutes) in 2012 shows cancer (70 deals) and infectious disease (64) as major areas of interest, as well as diagnostics/pharmacogenetics (68) (Fig. 1) . Harvard University and the University of Texas system top the list of universities with the most industry deals, and University College d ata p a g e npg
